---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004683"
form_type: "8-K"
ticker: "PHIO"
cik: "0001533040"
company_name: "Phio Pharmaceuticals Corp."
filed_at: "2024-07-05T23:59:59+00:00"
generated_at: "2026-05-31T23:20:37.054116+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Phio terminates $621K share purchase agreement with Triton Funds after stock falls below floor

## Summary
- On July 3, 2024, Phio terminated the Purchase Agreement with Triton Funds LP, effective immediately.
- The agreement allowed Triton to buy up to 95,833 shares at $6.48/share for gross proceeds up to $621,000.
- No shares were ever sold under the agreement; termination followed a $5.23 close on July 3, below the $6.48 floor.
- Phio's Board determined termination was advisable to pursue alternative financing.
- Press release states the agreement would have allowed Triton to purchase up to 18.8% of common stock.

## SEC filing metadata
- accession: 0001683168-24-004683
- form_type: 8-K
- ticker: PHIO
- cik: 0001533040
- company_name: Phio Pharmaceuticals Corp.
- filed_at: 2024-07-05T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533040/000168316824004683/0001683168-24-004683-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533040/000168316824004683/phio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004683
- JSON: https://secwatch.observer/filing/0001683168-24-004683.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004683.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.